Saturday, October 19, 2024 - 7:00 am - 8:00 am

Industry Sponsored Short Snapper Sessions #1

IL-23 Trials in Crohn's Disease: Fact or Fiction?

Learning Objectives: 

• Summarize the main outcomes from the IL-23 head-to-head trials in Crohn’s Disease
• Provide a comprehensive overview of the trial design and methodologies, and how they align with current clinical standards.
• Discuss the implications of the trial findings on current and future treatment strategies.

Dr. Neeraj Narula MD, MPH, FRCPC

Associate Professor of Medicine, Department of Medicine,  McMaster University
Program Director, IBD Fellowship

Dr. Neeraj Narula is an Associate Professor of Medicine at McMaster University and Staff Gastroenterologist at Hamilton Health Sciences, with a clinical and research focus in Inflammatory Bowel Diseases (IBD).  

He completed the Present-Levison Advanced Inflammatory Bowel Diseases Fellowship at Mount Sinai Hospital (New York, NY) in 2015 and a Masters of Public Health at Harvard TH Chan School of Public Health (Boston, MA) in 2018.  

He has over 140 peer-reviewed publications and 4 book chapters. He has been awarded over $3 million in research funding and grants. His research interests are predominantly in clinical epidemiology, nutrition, and pharmaceutical trials in IBD.  

His leadership roles within several national organizations include being Past-President of the Canadian IBD Research Consortium and VP-Treasurer for the Canadian Association of Gastroenterology. His recent awards include the Meeting of the Minds Junior Investigator Award (2020) and Crohn’s and Colitis Rising Star Award (2019).